Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 1 Date: 07 May 2023
Reviewer's report:
This article has great bias. I don't think revision can solve the problem with the article. Firstly,
there have been a large number of similar studies published. Secondly, the author cannot prove
whether the model constructed can be applied to other single center queues.
Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 1 Date: 07 May 2023
Reviewer's report:
This article has great bias. I don't think revision can solve the problem with the article. Firstly,
there have been a large number of similar studies published. Secondly, the author cannot prove
whether the model constructed can be applied to other single center queues.
Please review this paper.
user
Title: Construction of a novel signature based on immune-related lncRNA to identify high and
low risk pancreatic adenocarcinoma patients
Version: 1 Date: 07 May 2023
Reviewer's report:
This article has great bias. I don't think revision can solve the problem with the article. Firstly,
there have been a large number of similar studies published. Secondly, the author cannot prove
whether the model constructed can be applied to other single center queues.
assistant